Cover Image
Market Research Report

Companion Animal Vaccines Market, By Product Type, By Species Type, By Distribution Channel, and By Regions - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published by Coherent Market Insights Product code 924603
Published Content info 178 Pages
Delivery time: 2-3 business days
Price
Back to Top
Companion Animal Vaccines Market, By Product Type, By Species Type, By Distribution Channel, and By Regions - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Published: January 30, 2020 Content info: 178 Pages
Description

Companion animal vaccines are used to protect and treat companion animals such as cats, and dogs from diseases such as infectious canine hepatitis, parvovirus, rabies, and etc. Increasing expenditure on animal healthcare, increasing pet ownership, increasing incidence and prevalence of zoonotic disease, are major driver attributing to the growth of global companion animal vaccines market during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the global Companion Animal Vaccines and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Companion Animal Vaccines based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva Sante Animal S.A., Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Merial (Boehringer Ingelheim),Virbac, and Zoetis.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Companion Animal Vaccines report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Companion Animal Vaccines Market, By Product Type:
    • Attenuated Live Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Companion Animal Vaccines Market, By Species Type:
    • Canine
    • Avian
    • Feline
  • Companion Animal Vaccines Market, By Distribution Channel:
    • Veterinary Clinics
    • Veterinary Hospitals
    • Veterinary Research Institutes
    • Retail Pharmacies & Others
  • Companion Animal Vaccines Market, By Region:
    • North America
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Bayer Healthcare *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Vetoquinol S.A
    • Boehringer Ingelheim
    • Ceva Sante Animal S.A.
    • Eli Lilly and Company (Elcano)
    • Heska Co.
    • Merck Animal Health
    • Merial (Boehringer Ingelheim)
    • Virbac
    • Zoetis

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Species
    • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Product Launch
    • Regulatory Scenario

4. Global Companion Animal Vaccines Market, By Product Type, 2019 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Attenuated Live Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Conjugate Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Inactivated Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Subunit Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Toxoid Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • DNA Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Recombinant Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

5. Global Companion Animal Vaccines Market, By Species, 2019 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Canine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Avian
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Feline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

6. Global Companion Animal Vaccines Market, By Distribution Channel, 2019 - 2027, (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
    • Veterinary Clinics
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Veterinary Hospitals
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Veterinary Research Institutes
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Retail Pharmacies & Others
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Electronic Medical Records Market, By Region, 2019 - 2027, (US$ Mn)

    • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
    • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
    • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

    • Company Profiles
    • Bayer Healthcare
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Vetoquinol S.A
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Boehringer Ingelheim
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Ceva Sante Animal S.A.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Eli Lilly and Company (Elcano)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Heska Co.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merck Animal Health
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merial (Boehringer Ingelheim)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Virbac
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Zoetis
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top